- Fabio Turone
- Milan
A controversial cancer treatment will be given experimentally to 2600 patients with cancer in 21 hospitals around Italy after massive pressure from patients and the media. The treatment—based on a cocktail of drugs, including somatostatin and melatonin—has been developed by Professor Luigi Di Bella.
Professor Di Bella, aged 86, formerly held a temporary position as professor of physiology at the University of Modena. He has presented his protocol at a few meetings but has not published his research in a peer reviewed journal. Professor Di Bella says that he has been using the approach for more than 25 years and it is effective against all cancers without any side effects. He …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record







CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Transforming translation
Published 30 May 2012
Re: Bringing Nightingale down to size
Published 29 May 2012
Re: Avoid antimuscarinic drugs in people with dementia
Published 29 May 2012
Re: Strengthening primary health care: Related to the integration of medical training, community service need and health administration
Published 29 May 2012
Re: Strengthening primary health care: Related to the integration of medical training, community service need and health administration
Published 29 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (9 responses)
Published 2 May 2012 - 15:42
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27